Blueshift Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Blueshift Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000	Closed	-$218K	–	503
2023 Q1	$218K	Buy	+2,000	New	+$221K	0.09%	287
2022 Q3	–	Sell	-12,682	Closed	-$1.01M	–	908
2022 Q2	$1.01M	Buy	12,682 +3,747	+42%	+$355K	0.17%	191
2022 Q1	$940K	Buy	8,935 +1,654	+23%	+$161K	0.09%	286
2021 Q4	$785K	Buy	7,281 +410	+6%	+$44.7K	0.07%	355
2021 Q3	$753K	Buy	6,871 +3,682	+115%	+$382K	0.04%	496
2021 Q2	$299K	Sell	3,189 -6,747	-68%	-$621K	0.02%	730
2021 Q1	$915K	Buy	9,936 +6,231	+168%	+$526K	0.09%	294
2020 Q4	$271K	Buy	+3,705	New	+$275K	0.03%	548

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Blueshift Asset Management's HZNP Position: Q2 2023 in Review

Blueshift Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 2,000 shares — an estimated $218K sold.

Blueshift Asset Management first reported a position in HZNP in Q4 2020 and held it in 8 quarters. The position peaked at $1.01M in Q2 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Blueshift Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Blueshift Asset Management sold 2,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $218K.
Blueshift Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 8 quarters.
Blueshift Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.01M in Q2 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Blueshift Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.